English ticker view

CRSP

CRISPR THERAPEUTICS AG

This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.

Full Korean data view Search another ticker

Current price

$60.875

Public comments

13F holding rows

Insider trade rows

Public comments

Ranked by current return where prices are available.

13F direction

25 / 24

New or increased positions vs reduced or sold positions.

Insider activity

0 buyers

Based on SEC Form 4 market purchase and sale rows.

Latest comments

Most recent public records

No public comment records are connected to this ticker yet.

SEC 13F

Institution holding changes

JPMorgan Chase & Co.

sold out · May 13, 2026

+37.3%

Filing price $44.34 · Current $60.875

Nuveen Asset Management, LLC

sold out · Feb 14, 2025

+29.6%

Filing price $46.98 · Current $60.875

Dimensional Fund Advisors LP

decreased · May 7, 2026

+28.1%

Filing price $47.5251 · Current $60.875

Ameriprise Financial Inc

decreased · May 15, 2026

+28.0%

Filing price $47.5565 · Current $60.875

Envestnet Asset Management Inc

increased · May 4, 2026

+28.0%

Filing price $47.5698 · Current $60.875

LPL Financial LLC

decreased · May 6, 2026

+28.0%

Filing price $47.5698 · Current $60.875

Amundi

new · May 15, 2026

+28.0%

Filing price $47.57 · Current $60.875

Bank of New York Mellon Corp

unchanged · May 5, 2026

+28.0%

Filing price $47.57 · Current $60.875

Insider trades

SEC Form 4 summary

No insider summary is connected to this ticker yet.

Information only. WhenBuy summarizes public data and simple calculations. It is not a stock recommendation, and returns may not reflect dividends, taxes, FX rates, fees, splits, or exact trade timing.